Clinical Genomics Technologies

About Clinical Genomics Technologies

Clinical Genomics operates in the healthcare and biotechnology sector, specializing in the detection and monitoring of colorectal cancer. The company serves healthcare providers, patients, and diagnostic labs by offering advanced screening and monitoring solutions. Clinical Genomics leverages proprietary technology to provide more effective and economical tests compared to current standards. Their core products include an easy home collection stool test for detecting blood and the COLVERA blood test, which monitors for recurrence by detecting circulating tumor DNA (ctDNA). The business model is centered around selling these diagnostic tests to healthcare providers and labs, generating revenue through product sales and potentially through partnerships and licensing agreements. The market for colorectal cancer diagnostics is significant, given the prevalence of the disease and the need for early detection and ongoing monitoring. Clinical Genomics aims to improve affordability, usability, and accuracy in cancer detection, positioning itself as a key player in the global diagnostics market.